These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 34194826)
1. Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela. Bermúdez V; Salazar J; Fuenmayor J; Nava M; Ortega Á; Duran P; Rojas M; Añez R; Rivas-Montenegro A; Angarita L; Chacín M; Cano C; Velasco M; Rojas J J Obes; 2021; 2021():5514901. PubMed ID: 34194826 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China. Huang R; Cheng Z; Jin X; Yu X; Yu J; Guo Y; Zong L; Sheng J; Liu X; Wang S Ann Med; 2022 Dec; 54(1):622-632. PubMed ID: 35175162 [TBL] [Abstract][Full Text] [Related]
3. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY. Xie X; Li Q; Zhang L; Ren W Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802 [TBL] [Abstract][Full Text] [Related]
4. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus? Kavaric N; Klisic A; Ninic A J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28632304 [TBL] [Abstract][Full Text] [Related]
5. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome. Anik Ilhan G; Yildizhan B; Pekin T Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693 [TBL] [Abstract][Full Text] [Related]
6. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome. Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188 [TBL] [Abstract][Full Text] [Related]
7. Lipid accumulation product and visceral adiposity index: two indices to predict metabolic syndrome and insulin resistance in chronic kidney disease patients. Fahmy AM; El Shall N; Kabbash I; El Ahwal L; Selim A Endocr Regul; 2023 Jan; 57(1):99-105. PubMed ID: 37183690 [No Abstract] [Full Text] [Related]
8. Association of lipid accumulation product and visceral adiposity index with the risk of hypertension among oil workers in Xinjiang, China. Muheiyati G; Mei Y; Tao N PeerJ; 2023; 11():e15273. PubMed ID: 37214102 [TBL] [Abstract][Full Text] [Related]
9. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome. Wang H; Cao H; Cao J; Zhang L Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799 [TBL] [Abstract][Full Text] [Related]
10. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. Ramezani Tehrani F; Minooee S; Azizi F Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947 [TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Du T; Yuan G; Zhang M; Zhou X; Sun X; Yu X Cardiovasc Diabetol; 2014 Oct; 13():146. PubMed ID: 25326814 [TBL] [Abstract][Full Text] [Related]
12. Association of visceral adiposity index and lipid accumulation products with prediabetes in US adults from NHANES 2007-2020: A cross-sectional study. Qiu LT; Zhang JD; Fan BY; Li L; Sun GX PLoS One; 2024; 19(9):e0311312. PubMed ID: 39348367 [TBL] [Abstract][Full Text] [Related]
13. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Du T; Yu X; Zhang J; Sun X Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of visceral adiposity indices and lipid accumulation products in the identification of adults at high cardiovascular risk. Milla AMG; Chagas EBF; Miola VFB; Zanuso BO; Guiguer EL; Araújo AC; Tofano RJ; Quesada KR; Laurindo LF; Barbalho SM Clin Investig Arterioscler; 2023; 35(5):236-242. PubMed ID: 37121826 [TBL] [Abstract][Full Text] [Related]
15. Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study. Shreenidhi RA; Mahey R; Rajput M; Cheluvaraju R; Upadhyay AD; Sharma JB; Kachhawa G; Bhatla N J Hum Reprod Sci; 2024; 17(1):50-57. PubMed ID: 38665608 [TBL] [Abstract][Full Text] [Related]
16. Association of adiposity indicators with cardiometabolic multimorbidity risk in hypertensive patients: a large cross-sectional study. Dong T; Lin W; Zhou Q; Yang Y; Liu X; Chen J; Liu H; Zhang C Front Endocrinol (Lausanne); 2024; 15():1302296. PubMed ID: 38577567 [TBL] [Abstract][Full Text] [Related]
17. Association between obstructive sleep apnea and visceral adiposity index and lipid accumulation product: NHANES 2015-2018. Zhou T; Chen S; Mao J; Zhu P; Yu X; Lin R Lipids Health Dis; 2024 Apr; 23(1):100. PubMed ID: 38600516 [TBL] [Abstract][Full Text] [Related]
18. Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes. Ahn N; Baumeister SE; Amann U; Rathmann W; Peters A; Huth C; Thorand B; Meisinger C Sci Rep; 2019 Jul; 9(1):9693. PubMed ID: 31273286 [TBL] [Abstract][Full Text] [Related]
19. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839 [TBL] [Abstract][Full Text] [Related]
20. The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index. Rocha ALL; Baêta T; Nazareth IR; Costa JM; Caporalli JD; Oliveira MA; Couto MG; Azevedo RC; Comim FV; Oliveira FR; Reis FM; Cândido AL Arch Gynecol Obstet; 2024 Apr; 309(4):1643-1649. PubMed ID: 38321350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]